Vaccine maker CSL Seqirus has lined up yet another contract with the U.S. | With a $121.4 million award from the U.S.

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...

EST: Adds comments from CSL The U.S. has reportedly awarded $72M to GSK (NYSE:GSK), Sanofi (NASDAQ:SNY), and CSL (OTCQX:CSLLY ...

CSL Seqirus employees sometimes come to the company with a professional background that is outside the pharma sphere. Cris Blackhurst, for example, worked as a teacher's assistant for special ...

From on-campus basketball courts and wooded walking trails to complimentary box seats at Durham Bulls games, CSL Seqirus offers employees at its Holly Springs manufacturing facility an exciting ...

"Once again, we're honored to partner with BARDA on pandemic preparedness," said Marc Lacey, CSL Seqirus, Global Executive Director for Pandemic. "This expanded program will increase outbreak ...

In this sprawling factory, sheltered by thick pine groves, workers at CSL Seqirus are bottling millions of doses of a new ...

CSL Seqirus has secured a $121.4 million, multi-year award from the U.S. Department of Health and Human Services (HHS) to produce additional adjuvant, an ingredient in some vaccines that triggers ...

SUMMIT, N.J., Oct. 1, 2024 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), today announced data from a range of real-world evidence (RWE) studies, highlighting the important role ...

Biomedical Advanced Research and Development Authority (BARDA) and CSL Seqirus will expand their reserves of MF59 ® adjuvant to the equivalent of 40 million doses as part of the National Pre ...